Pune, Maharashtra -- (SBWIRE) -- 04/19/2017 -- Market Scenario:

Human insulin is also known as synthetic insulin which is prepared in laboratory and has same characteristics like natural insulin. Human insulin was developed through the 1960s and 1970s and approved for pharmaceutical use in 1982. Before the invention of human insulin animal insulin, usually a purified form of porcine was used.

The global Human Insulin Market is expected to reach up to $40 billion by the end of the forecasted period and is expected to grow at a CAGR of ~10-12%.

The major factors contributing to the market growth are; increase in prevalence of diabetic population, rise in geriatric population, rising awareness of diabetes and rising prevalence of obesity.

"Ask for your specific company profile and country level customization on reports"

Key Players
-Adocia (France.)
-Merck & Co. (U.S.)
-Julphar (UAE)
-Bristol-Myers Squibb Company (U.S.)
-GlaxoSmithKline Plc (U.K.)
-Biocon Ltd. (India)
-Tonghua Dongbao Pharmaceuticals Co., Ltd. (China)
-Oramed Pharmaceuticals, Inc. (Israel)
-Novo Nordisk A/S (Denmark)

Requset a Sample Report @ https://www.marketresearchfuture.com/sample_request/951

However, strict regulatory requirements for approval of insulin and high cost of analog are inhibiting the growth of the global human insulin market. Along with that, delayed onset of action, and various side effects of human insulin are also limiting the growth of this market across the globe.

Key Findings

-Increasing prevalence of diabetic population, rising prevalence of obesity, and rise in geriatric population are major factors driving the growth of the human insulin market

-Strict regulatory requirements for approval of insulin and high cost of insulin analog inhibits the growth of the Human Insulin Market

-Geographically, North America has the largest share in global human insulin market, while Asia-Pacific has emerged as the fastest growing region

-Based on the type, modern human insulin has the largest market share in the human insulin market

Segments by Types

Modern Human Insulin
Long Acting Human Insulin
Rapid Acting Human Insulin
Premixed Human Insulin

Traditional Human Insulin
Short Acting Human Insulin
Intermediate Acting Human Insulin

Regional Analysis of Human Insulin Market

Globally North America is the largest market for human insulin, large share of this market is attributed to growing prevalence of diabetes and obesity. The North American market for human insulin is expected to grow at high CAGR in the forecasted period. Europe is the second-largest market for human insulin, which is expected to grow at good CAGR.

Browse Report @ https://www.marketresearchfuture.com/reports/human-insulin-market

Table of Content
1. Report Prologue
2. Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
2.3 Market Structure
2.4. Market Segmentation
3. Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Mega Trends
4.5 Macroeconomic Indicators
4.6 Important Pointers By Industry Experts
4.6.1 Fastest Growing Market
4.6.2 Growth Prospects
4.7 Regulations/Acts
5. Market Factor Analysis
5.1 Value Chain Analysis
5.2 Porters
6. Human Insulin Market 2016-2020: By Types (Us $ Million)
6.1 Introduction
6.2 Historic Market Growth
6.3 Market Size (Sub Segments)
6.3.1 Traditional Human Insulin
6.3.1.1 Short Acting Human Insulin
6.3.1.2 Intermediate Acting Human Insulin
6.3.2 Modern Human Insulin
6.3.2.1 Long Acting Human Insulin
6.3.2.2 Rapid Acting Human Insulin
6.3.2.3 Premixed Human Insulin
7. Human Insulin Market, By Region Market Value & Volume Forecast (Us $ Million)
7.1 Introduction
7.2 Market Size by Region
7.2.1 Americas
7.2.1.1 North America
7.2.1.1.1 US
7.2.1.1.2 Canada
7.2.1.2 Latin America
7.2.2 Europe
7.2.2.1 Western Europe
7.2.2.1.1 Germany
7.2.2.1.2 France
7.2.2.1.2 Italy
7.2.2.1.4 Spain
7.2.2.1.5 UK
7.2.2.1.6 Rest Of Western Europe
7.2.3.1 Eastern Europe
7.2.3 Asia-Pacific
7.2.3.1 China
7.2.3.2 India
7.2.3.3 Japan
7.2.3.4 Rest of Asia Pacific
7.2.4 Middle East & Africa
8. Company Landscape
8.1 Introduction
8.2 Product Launch/Development
8.3 Partnerships and Collaborations
8.4 Acquisitions
8.5 Business Expansion
Continue…………..

Modern human insulin, also known as analog insulin, is prescribed by physicians for the treatment of diabetes. It is the customized form of traditional human insulin and provides effective results in comparison to traditional human insulin.

Related Report

Astigmatism Market Information, by type (Myopic Astigmatism, Hyperopic Astigmatism and others), by treatment (Corrective Lenses, Orthokeratology (Ortho-K), Surgeries and others), by end user (Hospital, Clinics and others) - Forecast to 2022 https://www.marketresearchfuture.com/reports/astigmatism-market

About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.